Real-World Outcomes of Everolimus and Exemestane for the Treatment of Metastatic Hormone Receptor-Positive Breast Cancer in Patients Previously Treated With CDK4/6 Inhibitors.

Autor: Hanjie Mo, Renna, Catherine E., E Moore, Halle C., Abraham, Jame, Kruse, Megan L., Montero, Alberto J., LeGrand, Susan B., Lu Wang, Thomas Budd, G., Mo, Hanjie, Moore, Halle C F, Wang, Lu, Budd, G Thomas
Zdroj: Clinical Breast Cancer; Feb2022, Vol. 22 Issue 2, p143-148, 6p
Databáze: Complementary Index
Externí odkaz: